← Back to headlines
Everest Medicines Acquires Greater China Rights for LENZ Therapeutics' VIZZ® Eyedrop
Everest Medicines has acquired the rights for Greater China to LENZ Therapeutics' presbyopia eyedrop, VIZZ®, expanding its portfolio in the region.
8 Jun, 07:02 — 8 Jun, 07:02
Sources
Showing 1 of 1 sources
